Sort by: Date added | Date Published | Most Viewed

Headlines Tagged with Investing 4,165 headlines found

12 Views

[New Jersey] SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Philip Morris International Inc. of Class Action Lawsuit and Upcoming Deadline - PM

Defendants made false and/or misleading statements and/or failed to disclose that: (1) there were irregularities in the clinical experiments that underpin Philip Morris' application to the U.S. Food and Drug Administration ("FDA") for approval of its iQOS
PR Newswire
added Jan 30, 2018 16:51
17 Views

Did the FDA Just Doom Philip Morris International's Future?

With so much on the line for Philip Morris' future, investors will have to watch the FDA closely to see what future developments say about the prospects for iQOS in the U.S. market.
Motley Fool
added Jan 30, 2018 14:51
41 Views

Americas Tobacco: TPSAC vote delays/lowers the likelihood of MRTPA approval for iQOS; PMTA approval still likely

While the FDA decision is still pending (and the TPSAC vote is not binding), we believe yesterday's votes lower the likelihood of iQOS obtaining a reduced risk claim. From a stock standpoint, we still see strong (30%) share price upside potential in PM an
Goldman Sachs Research
added Jan 27, 2018 02:54
6 Views

[UK] Tobacco, oil, and arms – where Imperial is investing its money

An analysis of Imperial College London’s endowment fund has revealed significant direct and indirect investments in the tobacco, fossil fuel, weapons, and pharmaceutical industries..."Even College’s commitment to avoid investing in tobacco seems paper-th
Felix-Imperial Colleges Student Newspaper
added Jan 27, 2018 02:31
33 Views

How Should Investors React To FDA Rejection Of iQOS?

The headline doesn't read well, but in reality this is not yet a cause for concern over the eventual implementation of iQOS in the United States. In fact, when you consider the sum of all parts, I arrive at an overwhelming conclusion that iQOS will find
Seeking Alpha blog network
added Jan 26, 2018 12:53
10 Views

Philip Morris, Altria hit by FDA advisory panel ruling on IQOS devices

Shares of Philip Morris International and Altria Group took a hit after a Food and Drug Administration advisory panel rejected Philip Morris’s proposed claim that its IQOS tobacco heating devices present less of a health risk than the traditional version
Financial Times (uk)
added Jan 26, 2018 12:01
11 Views

Philip Morris Falls as Tobacco Device Hits Snag on Health Risks

Outside experts advising the Food and Drug Administration concluded in a 8-0 vote that Philip Morris hadn’t shown that iQos would be less risky than cigarettes for smokers that make a complete switch. One panel member abstained. The vote was the culminat
Bloomberg News
added Jan 25, 2018 18:04
16 Views

Americas Tobacco: TPSAC Meeting Day 1: TPSAC expresses some concerns on IQOS MRTPA

PM's totality of evidence is supportive of MRTPA claim, in our view - We believe that PM has presented compelling evidence that would support the claim that IQOS leads to significantly reduced Harmful and Potentially Harmful Constituents (HPHC) productio
Goldman Sachs Research
added Jan 27, 2018 02:51
2 Views

Cigarettes Stocks' Research Reports Released on British American Tobacco, Altria, Philip Morris, and Vector

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on BTI, MO, PM, and VGR which can be accessed for free by signing up to www.wallstequities.com/registration. Pre-market today, WallStEq
PR Newswire
added Jan 23, 2018 00:42
24 Views

Tobacco’s a Hot Prospect in 2018

Bennett writes that Philip Morris should benefit from the Tobacco Products Scientific Advisory Committee's review of its iQOS system expected next week, which could help it gain ground after recent pressures. At Altria, he writes that the focus will be on
Barron's
added Jan 22, 2018 05:45
Sign up for daily headlines All Headlines Featured Headlines U.S. Headlines International Headlines